Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: Sugammadex, neostigmine or no reversal

European Journal of Anaesthesiology

Volumn 31, Issue 8, 2014, Pages 423-429

  Ledowski, Thomas ^a   Falke, Laura ^b   Johnston, Faye ^a   Gillies, Emily ^a   Greenaway, Matt ^a   De Mel, Ayala ^a   Tiong, Wuen S ^a   Phillips, Michael ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; GLYCOPYRRONIUM BROMIDE; NEOSTIGMINE; SEROTONIN 3 ANTAGONIST; SUGAMMADEX; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; COHORT ANALYSIS; COMORBIDITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DYSPNEA; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LENGTH OF STAY; LEUKOCYTE COUNT; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PNEUMONIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; RECOVERY ROOM; RESIDUAL NEUROMUSCULAR BLOCKADE REVERSAL; RETROSPECTIVE STUDY; SMOKING HABIT; TEACHING HOSPITAL; THORAX RADIOGRAPHY; TURNOVER TIME; AGING; LUNG DISEASES; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE NAUSEA AND VOMITING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905514448     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000010     Document Type: Article

References (17)

1. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120-128.
2. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008; 109:816-824.
3. Naguib M, Kopman AF, Lien CA, et al. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111:110-119.
4. Abrishami A, Ho J, Wong J, et al. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database Syst Rev 2009;CD007362.
5. Ledowski T, Hillyard S, O'Dea B, et al. Introduction of sugammadex as standard reversal agent: impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. Ind J Anaesth 2013; 57: 46-51.
6. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomized and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-1103.
7. Grosse-Sundrup M, Henneman PJ, Sandberg WS, et al. Intermediate acting nondepolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345:e6329.
8. Eikerman M, Groeben H, Bunten B, Peters J. Fade of pulmonary function during residual neuromuscular blockade. Chest 2005; 127:1703-1709.
9. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postoperative care unit. Anesth Analg 2008; 107:130-137.
10. Ledowski T, Hillyard S, Kozman A, et al. Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs. Anaesth Intensive Care 2012; 40:340-343.
11. Watts RW, London JA, van Wijk RM, Lui YL. The influence of unrestricted use of sugammadex on clinical anaesthetic practice in a tertiary teaching hospital. Anaesth Intensive Care 2012; 40:333-339.
12. Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth 2012; 108:236-239.
13. Parra-Sanchez I, Abdallah R, You J, et al. A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery. Can J Anaesth 2012; 59:366-375.
14. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1042-1048.
15. Kim KS, Cheong MA, Lee HJ, Lee JM. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesth Analg 2004; 99:1080-1085.
16. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111:129-140.
17. Agostini P, Naidu B, Cieslik H, et al. Comparison of recognition tools for postoperative pulmonary complications following thoracotomy. Physiotherapy 2011; 97:278-283.